CoChat

α‐synuclein RT‐QuIC in cerebrospinal fluid of LRRK 2‐linked Parkinson's disease

Open access
Garrido, Alicia, Fairfoul, Graham, Tolosa, Eduardo S., Martí, Maria José, Green, Alison, the Barcelona LRRK2 Study Group · 2019 · Annals of Clinical and Translational Neurology
Cited by 109

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Background: Leucine‐rich kinase 2 (LRRK 2)‐linked Parkinson's disease (PD) is clinically indistinguishable from idiopathic PD (IPD). A pleiotropic neuropathology has been recognized but the majority of studies in LRRK 2 p.G2019S patients reveal Lewy‐type synucleinopathy as its principal histological substrate. To date no in vivo biomarkers of synucleinopathy have been found in LRRK 2 mutation carriers. Objectives: We used real‐time quaking‐induced conversion (RT‐Qu IC) technique to assess the presence of alpha‐synuclein (a‐syn) aggregates in cerebrospinal fluid (CSF) of LRRK 2 p.G2019S carriers. Methods: CSF samples of 51 subjects were analyzed: 15 LRRK 2 p.G2019S PD, 10 IPD, 16 LRRK 2 p.G2019S nonmanifesting carriers (NMC) and 10 healthy controls. The presence of parkinsonism and prodromal symptoms was assessed in all study subjects. Results: Forty percent (n = 6) L RRK 2‐PD, and 18.8% (n = 3) LRRK2‐NMC had a positive a‐syn RT‐Qu IC response. RT‐Qu IC detected IPD with 90% sensitivity and 80% specificity. No clinical differences were detected between LRRK 2‐PD patients with positive and negative RT‐Qu IC. A positive RT‐Qu IC result in LRRK 2‐NMC occurred in a higher proportion of subjects meeting the Movement Disorder Society research criteria for prodromal PD. Interpretation: RT‐Qu IC detects a‐syn aggregation in CSF in a significant number of patients with LRRK 2‐PD, but less frequently than in IPD. A small percentage of LRRK 2‐NMC tested also positive. If appropriately validated in long‐term studies with large number of mutation carriers, and hopefully, postmortem or in vivo confirmation of histopathology, RT‐Qu IC could contribute to the selection of candidates to receive disease modifying drugs, in particular treatments targeting a‐syn deposition.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/acn3.772

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

Metadata

Authors
Garrido, A., Fairfoul, G., Tolosa, E. S., Martí, M. J., Green, A., & the Barcelona LRRK2 Study Group
Venue
Annals of Clinical and Translational Neurology
Publisher
Wiley
Published
2019-05-09
Volume
6
Issue
6
Pages
1024-1032
ISSN
2328-9503 (ISSN-L)
OpenAlex
W2944521680
Cited by
109
References
8
FWCI
7.14
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.